APA (7th ed.) Citation

JJ, P., KN, B., C, Z., N, D., DF, C., WC, E., . . . EM, E. (2024). A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma. Frontiers in oncology, 14, 1449401. https://doi.org/10.3389/fonc.2024.1449401

Chicago Style (17th ed.) Citation

JJ, Pu, et al. "A Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab in Treating Patients over 50 Years Old with Mantle Cell Lymphoma." Frontiers in Oncology 14 (2024): 1449401. https://doi.org/10.3389/fonc.2024.1449401.

MLA (9th ed.) Citation

JJ, Pu, et al. "A Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab in Treating Patients over 50 Years Old with Mantle Cell Lymphoma." Frontiers in Oncology, vol. 14, 2024, p. 1449401, https://doi.org/10.3389/fonc.2024.1449401.